Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Markets react as Trump signals an interim Iran deal to reopen the Strait of Hormuz. The move could ease shipping disr...
Valr confirms a Kenya-focused expansion as regulators finalize digital asset rules and Kenya’s fintech scene accelera...
A wave of borrowing among AI builders is reshaping how investors view growth. NVIDIA, Oracle, and SpaceX are tapping ...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Broadcom is defying a broad market panic as AI-driven demand fuels strong cash flow and robust margins. Here's why in...
A U.S. startup says its graphene-based, non-lithium energy storage solution is safer and faster to deploy, reporting ...
Bloom Energy posted a robust Q1 2026 and raised guidance, fueling a sharp stock surge. Yet traders and analysts quest...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
Tori Spelling says her California rental, home to five children, costs $12,000 a month and feels chaotic. The remark ...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Nvidia races toward a near-$5 trillion market value while its on-site cafeteria charges for many items. The contrast ...